Vaccine News and Research

Latest Vaccine News and Research

Vaccinated seropositive individuals are able to induce high anti-spike SIgA responses

Results of a new study show that the induction of anti-SARSCoV-2 spike saliva SIgA antibodies after vaccination is independent of the gender or type of vaccine received.

14 Dec 2021

Changes in trajectory of long COVID symptoms before vaccination

A new preprint describes the results of a study examining this aspect of the disease.

14 Dec 2021

Assay for the identification of SARS-CoV-2 Spike reactive T and B cells

An interesting new paper presents a new assay for B and T lymphocytes in individuals infected with SARS-CoV-2.

14 Dec 2021

Evaluating the exclusion of unvaccinated people in the prevention of SARS-CoV-2 transmission

New study results suggest that the numbers needed to exclude model and baseline infection risk could be key indicators of the drawbacks and benefits of vaccine mandates and vaccine passports.

14 Dec 2021

Risk of SARS-CoV-2 reinfection in children compared to adults

The current study aimed to explore the rate and risk of SARS-CoV-2 reinfections in children.

14 Dec 2021

New mRNA vaccine platform provides stronger protection against SARS-CoV-2 delta variant

A group of researchers from various institutions developed a nucleoside-modified mRNA vaccine that encodes the SARS-CoV-2 N protein (mRNA-N) and is formulated in lipid nanoparticles for this investigation (LNP).

14 Dec 2021

Machine learning method for determining impact of mutations in the SARS-CoV-2 RBD on binding and antibody escape

Deep mutational learning (DML) is a technique developed by researchers from multiple institutions that combines experimental yeast display screening of RBD mutagenesis libraries with deep sequencing and machine learning.

14 Dec 2021

Characteristics of SARS-CoV-2 breakthrough infections tracked in large US study

Researchers from Microsoft Corporation, Fred Hutch Cancer Research Center, and the University of Washington recently published a report on the preprint server medRxiv* wherein they studied a de-identified cohort from the United States medical claims records from Change Healthcare to estimate the risk of hospitalization and death, by vaccine type and by previous SARS-CoV2 infection, among SARS-CoV-2 breakthrough infections in fully vaccinated individuals.

14 Dec 2021

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections.

13 Dec 2021

Omicron variant may strike double vaccinated

Largely, scientists are skeptical that the Omicron variant can infect vaccinated individuals. However, a new study published on the medRxiv* preprint server has conducted neutralization assays using an Omicron isolate obtained from patients residing in the United Kingdom.

13 Dec 2021

COVID-19 vaccines offer protection for multiple myeloma patients, but lesser than other cancer survivors

For patients with the blood cancer multiple myeloma, vaccination against COVID-19 provides some protection against coronavirus infection but to a far lower degree than the general population of cancer survivors, a new study by Dana-Farber Cancer Institute investigators shows.

13 Dec 2021

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

A new study published on the bioRxiv preprint server has hypothesized that T cell receptors (TCR) repertoire can measure the response to vaccines, as it would identify the TCR of clones that respond to the vaccination.

13 Dec 2021

Characteristics of vaccine breakthroughs in fully vaccinated individuals in France with delta variant

In a recent observational study, scientists have described the characteristics of VBIs in fully vaccinated individuals in France.

13 Dec 2021

Novel assay using finger-prick samples provides COVID-19 vaccine efficacy data

Researchers estimate vaccine efficacy over a period post-vaccination using quantitative antibody assay on finger-prick blood samples.

13 Dec 2021

NHS COVID Pass rolled out to fully vaccinated 12-15 year olds for international travel

Today, the NHS COVID pass will be rolled out to 12-15 year olds for international travel, allowing even more people to be able to prove their vaccine status.

13 Dec 2021

SARS-CoV-2 omicron variant may evade host immune responses

A recent study has demonstrated that the omicron variant of severe acute respiratory syndrome coronavirus 2 has a higher ability to evade antibody-mediated neutralization than other variants of concern.

13 Dec 2021

Third dose of SARS-CoV-2 vaccine increases protection against omicron variant

A new study examines the variation in vaccine effectiveness against virus variants using estimated reductions in neutralizing antibody levels from published studies.

13 Dec 2021

750 Armed Forces personnel step up to accelerate the vaccine booster program

750 Armed Forces personnel have been made available to support the NHS, the Department of Health and Social Care and Scottish Government to accelerate the vaccine booster program.

13 Dec 2021

Seasonal coronaviruses may help estimate SARS-CoV-2 reinfection risk

New research suggests that common human coronaviruses, such as those that cause the common cold, could also shed light on the patterns of SARS-CoV-2 reinfection.

13 Dec 2021

MV130 immunotherapy boosts natural and vaccine-induced SARS-CoV-2 immunity in mice

A new mouse study found that intranasal administration of MV130 protected against severe acute respiratory syndrome coronavirus 2.

13 Dec 2021

Vaccine News and Research

Latest Vaccine News and Research

Vaccinated seropositive individuals are able to induce high anti-spike SIgA responses

Changes in trajectory of long COVID symptoms before vaccination

Assay for the identification of SARS-CoV-2 Spike reactive T and B cells

Evaluating the exclusion of unvaccinated people in the prevention of SARS-CoV-2 transmission

Risk of SARS-CoV-2 reinfection in children compared to adults

New mRNA vaccine platform provides stronger protection against SARS-CoV-2 delta variant

Machine learning method for determining impact of mutations in the SARS-CoV-2 RBD on binding and antibody escape

Characteristics of SARS-CoV-2 breakthrough infections tracked in large US study

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

Omicron variant may strike double vaccinated

COVID-19 vaccines offer protection for multiple myeloma patients, but lesser than other cancer survivors

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

Characteristics of vaccine breakthroughs in fully vaccinated individuals in France with delta variant

Novel assay using finger-prick samples provides COVID-19 vaccine efficacy data

NHS COVID Pass rolled out to fully vaccinated 12-15 year olds for international travel

SARS-CoV-2 omicron variant may evade host immune responses

Third dose of SARS-CoV-2 vaccine increases protection against omicron variant

750 Armed Forces personnel step up to accelerate the vaccine booster program

Seasonal coronaviruses may help estimate SARS-CoV-2 reinfection risk

MV130 immunotherapy boosts natural and vaccine-induced SARS-CoV-2 immunity in mice

Industry Focus eBook - Infectious Diseases (2nd Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Vaccine News and Research

Latest Vaccine News and Research

Industry Focus eBook - Infectious Diseases (2nd Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in